Endothelial Function in Patients with Multiple Sclerosis: The Role of GLP-1 Agonists, Lipoprotein Subfractions, and Redox Balance.

Miroslava HardonovaPavel SiarnikMonika SivakovaBianka SuchaAdela PenesovaZofia RadikovaAndrea HavranovaRichard ImrichMiroslav VlcekIngrid ZitnanovaGeorgi KrastevMaria KiacikovaBranislav KollarPeter Turcani

Published in: International journal of molecular sciences (2023)

Our results suggest that the application of additional GLP-1a therapy may have atheroprotective and antioxidant effects in MS patients with high MS activity and thus may prospectively mitigate their vascular risk. However, the lipoprotein profile may also play an important role in the atherogenic risk of MS subjects.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
low density lipoprotein
anti inflammatory
mesenchymal stem cells
cell therapy
smoking cessation